Morning Guru @davybabyk
Thanks for your insightful response. I really appreciate the contributions from yourself and others that even someone like me with a very non-scientific background can understand. I find the science and this whole field fascinating and to think that we could be invested in a company that potentially cures cancer is on one hand hard to believe but on the other becoming more believable every day.
I hope to see the day when if someone gets diagnosed with cancer early and the GP say's "no problem we'll just give you a little dose of CF33 and check you in a month."
The current share price could be the greatest buying opportunity in a lifetime, we shall see. Opening another 3 trial sites for Vaccinia is huge news and wouldn't be happening if there were any issues. It's just full steam ahead with this team.
In the meantime I'll happily take your advice and get out on my mountain bike in the muddy Adelaide Hills.
Have a great weekend Guru Dave (that might stick) and all the IMU faithful
- Forums
- ASX - By Stock
- IMU
- The CF33, Vaxinia and Oncarlytics Deal
The CF33, Vaxinia and Oncarlytics Deal, page-744
-
- There are more pages in this discussion • 344 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $357.0M |
Open | High | Low | Value | Volume |
4.8¢ | 4.8¢ | 4.7¢ | $379.2K | 7.937M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 3773908 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 1293222 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 3552632 | 0.047 |
23 | 3044504 | 0.046 |
30 | 3803872 | 0.045 |
40 | 6966738 | 0.044 |
29 | 3216810 | 0.043 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 688107 | 6 |
0.049 | 3497564 | 11 |
0.050 | 6853048 | 24 |
0.051 | 2446049 | 14 |
0.052 | 1856295 | 13 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online